Objectives: The hybrid approach achieves stage 1 palliation of hypoplastic left heart syndrome with flow and physiologic characteristics that are different from those of the surgical Norwood circulations. In addition to having branch pulmonary arterial banding regulating the balance between pulmonary and systemic blood flows, coronary and cerebral perfusion are dependent on retrograde flow through the native aortic arch when aortic atresia is present. Accordingly, we used computational modeling to assess the effects of pulmonary artery banding diameter and retrograde aortic arch hypoplasia or obstruction on the hybrid stage 1 circulation, including the influence on systemic and cerebral oxygen deliveries.
Conclusions: These computational simulations of the stage 1 hybrid palliation for hypoplastic left heart syndrome with aortic atresia suggest that small differences in the degree of branch pulmonary arterial banding can result in significant changes in the overall performance of the hybrid palliation. Furthermore, retrograde aortic arch hypoplasia or obstruction can lead to suboptimal cerebral and coronary perfusion. Precise pulmonary artery banding may be important to optimize interstage physiology in patients undergoing the hybrid approach, and pre-interventional imaging of the aortic arch and isthmus should be performed to rule out potential for postprocedural suboptimal cerebral and coronary perfusion. (J Thorac Cardiovasc Surg 2013;146:1341-8)
The hybrid procedure for hypoplastic left heart syndrome (HLHS) was introduced in 1993 as an alternative approach to stage 1 palliation. 1 Similar to the surgical Norwood procedures, the objective of the hybrid palliation is to maintain adequate systemic perfusion and control pulmonary blood flow to achieve optimal systemic, cerebral, and coronary oxygen delivery. However, the hybrid approach achieves these goals through interventional stenting of the ductus arteriosus to provide systemic flow (Qs) and surgical bilateral pulmonary artery (PA) banding to restrict pulmonary flow (Qp). An atrial procedure such as septectomy, or septostomy or stent, is frequently performed to ensure an unobstructed pulmonary venous return. 2 Therefore, there are important differences in the palliative circulations achieved between the surgical Norwood and the hybrid approach. In the surgical Norwood circulation, Qp is regulated via a systemic-pulmonary shunt, and the right ventricular outflow tract is reconstructed such that unobstructed systemic and cerebral perfusion occur in an antegrade manner. In the hybrid palliation, balancing Qp:Qs to achieve optimal systemic oxygen delivery through bilateral PA bands can be challenging and may place additional afterload to the systemic right ventricle. Moreover, in variants where aortic atresia or critical aortic stenosis is present, coronary and cerebral perfusion in the hybrid approach would rely on retrograde flow through the aortic arch. In patients with severe aortic arch hypoplasia or aortic isthmus coarctation, there can be insufficient retrograde aortic flow leading to coronary and cerebral malperfusion. 3 We have previously used a multiscale modeling approach to examine some of the physiologic and hemodynamic differences between the hybrid and the surgical Norwood circulations. 4 In this study, we further examined the effects of branch PA banding and investigated the influence of retrograde aortic arch obstruction (RAAO) due to arch hypoplasia or isthmus coarctation on cerebral and coronary perfusion.
MATERIALS AND METHODS
The multiscale modeling method used in this study consists of coupling a 3-dimensional (3D) finite volume model of the anatomic region reconstructed with the hybrid procedure to a zero-dimensional lumped parameter network (LPN) representing the whole circulation outside the treated domain, as described and validated previously. [4] [5] [6] [7] [8] Figure 1 illustrates, as an example, the multiscale model with 2-mm pulmonary bandings, 5-mm ascending aorta and transverse aortic arch diameter, and no coarctation. Multiscale simulations provide detailed fluid dynamics at any part of the anatomic site of interest and both flow and pressure values in the remaining circulatory system. From these values, averaged over a cardiac cycle, it is then possible to calculate physiologic parameters, such as systemic oxygen delivery and single ventricle efficiency, which better describe the hemodynamic effects of the specific hybrid palliation.
Three-Dimensional Models
Three different sets of 3D rigid-walled models reproducing stage 1 hybrid palliation were developed. The first set comprised 5 models with varying PA banding diameters, ranging from 1.5 to 3.5 mm with steps of 0.5 mm. Because the hybrid approach does not involve the aortic arch reconstruction, in contrast to the classic Norwood procedures, these models were characterized by a 5-mm aortic arch diameter, without isthmus coarctation, to eliminate the additional effect of RAAO. They are described in detail in a previous study. 9 In a second set of simulations, ascending aorta and transverse aortic arch diameters were varied from 5 to 2 mm with steps of 1 mm to evaluate the fluid dynamic effects in hybrid patients with different degrees of aortic arch hypoplasia. The 4 models were reproduced with a bilateral PA banding fixed to 2 mm, in agreement with simulation results obtained from the first set of models. 4, 9 Last, models with isthmus coarctations of 2.5, 3.0, 4.0, and 5.0 mm (no coarctation) were simulated with branch PA banding of 2 mm and aortic arch diameter of 5 mm. Figure 2 shows the 3 sets of 3D models developed in this study.
All models had a fixed 1.6-mm banding length and 7-mm arterial duct diameter. Although some surgeons apply shorter or longer PA bands, the length of the PA band has minimal effect on overall resistance at the branch PA, as shown mathematically in Appendix A, where doubling the banding length results in negligible change in pressure decrease. Likewise, practice variation also exists on the size of the ductal stent during hybrid palliation with reported ductal stent varied from 7 to 10 mm. Dimensions of the 3 brachiocephalic vessels and pulmonary and coronary arteries were the same, obtained from angiograms of a group of patients before stage 2 palliation, as previously described. 10 Meshes were developed with Gambit (ANSYS, Inc, Canonsburg, Pa) using approximately 160,000 4-node tetrahedral volumetric elements for each computational fluid dynamics (CFD) model, after conducting a mesh sensitivity analysis previously described in detail. 7 Blood was assumed to be an incompressible Newtonian fluid with density and a dynamic viscosity equal to 1060 kg$m À3 and 0.005 kg$m À1 $s À1 , respectively.
Lumped Parameter Network
An identical LPN was coupled to each CFD model. On the basis of the pre-stage 2 clinical data collected from catheterization examinations of 28 patients with HLHS, 5,10 the LPN described the entire body circulation of a generic child with HLHS with a body surface area of 0.33 m 2 , outside of the blood volume domain represented by the 3D models. It comprised 5 subsystems similar to those developed in previous studies of ours: heart, upper and lower systemic circulation, pulmonary circulation, and coronary circulation. [4] [5] [6] 8 The heart, the atria, and the single ventricle were modeled with time-varying elastances. A linear resistance was used to represent a nonrestrictive atrial septal defect, whereas the atretic aortic and mitral valves were reproduced by means of nonlinear resistances. 11 The systemic and pulmonary vascular subsystems were in turn divided into arterial and venous compartments. The intramyocardial pressure acting on the coronary circulation was accounted for with a pressure generator controlled by the single ventricle pressure. The main assumptions regarding the LPN were as follows: pulmonary vascular resistance of 2.3 mm Hg$m 2 $L À1 $min, systemic vascular resistance of 21.6 mm Hg$m 2 $L À1 $min, and heart rate of 120 beats/min. Additional hypotheses were made for the calculation of the oxygen delivery and saturations: hemoglobin value of 16.52 g$dL À1 , oxygen consumption of 156.83 mL$min À1 $m À2 , and pulmonary venous oxygen saturation of 98%.
Multiscale Solution
In regard to the fluid domain represented by the CFD models described earlier, the mass and momentum conservation equations (ie, the Navier-Stokes equations) were solved with the finite volume method implemented in Fluent (ANSYS, Inc). At the same time, a nonlinear algebraic and ordinary differential equation system resolved the fluid dynamic variables of the LPN. Interface conditions enabled the coupling between the 3D model and the LPN: Uniform time-dependent pressures were imposed at the boundaries of the CFD domain, whereas flow rates averaged over each boundary cross-sectional area were passed to the LPN. 8 In addition, the local velocity profiles were not forced, but
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calculated, at each time instant to allow detection of possible reversal flows at the interfaces.
All simulations were carried out on an Intel Core 2 Duo 3 GHz personal computer (Intel Corp, Santa Clara, Calif). To guarantee a stable computational solution, a minimum of 4 cardiac cycles was simulated for each model with a time-step fixed to 10 À4 seconds. The time required for the simulation of 1 cardiac cycle was approximately 12 hours. A segregated solver and the implicit Euler method for time integration were identically applied to the 3D models by means of the fluid dynamic code Fluent (ANSYS, Inc). On the basis of various flows obtained from the simulations, systemic and cerebral oxygen deliveries (mlO 2 $min À1 $m À2 ) were calculated as follows 4,5 :
where Q s and Q cer are the systemic and cerebral volume flow rates and C art O 2 is the oxygen arterial content. Q cer is calculated as the sum of the flow rates through the left and right carotid arteries.
RESULTS
For each model, the multiscale approach provides solutions to both pressure and flow dynamics and to physiologic variables, such as oxygen delivery and cardiac output. Variables derived from the 3D models include pulmonary arterial pressure and flow, coronary arterial flow and perfusion pressure, and Qp:Qs ratio. Cardiac output is the summation of flows between Qs and Qp. Right ventricular performance, including ejection fraction, stroke work, and mechanical efficiency (ratio of stroke work and total mechanical energy), can be evaluated from pressure-volume loops generated by the heart. Moreover, oxygen transport equations, including Equations 1 and 2, can be combined with the multiscale approach, allowing calculations of systemic arterial and mixed venous oxygen saturations, as well as systemic and cerebral oxygen deliveries. Because of the large number of potential variables that can be generated with each simulation, only those that are most clinically relevant are presented. Table 1 summarizes these results from simulations that examined the effects of bilateral PA banding diameters, whereas Table 2 presents those data detailing the influences of aortic arch hypoplasia and isthmus coarctation. In both, results obtained from the reference model (no coarctation, 2.0-mm pulmonary bandings, 5-mm aortic arch) were highlighted. Figure 3 graphically demonstrates the effects of PA banding diameter on Qp and Qs, as well as those on systemic arterial and mixed venous oxygen saturations. Figure 4 shows the influence of aortic arch size and degree of isthmus coarctation on both cerebral and coronary blood flow.
As bilateral PA banding becomes more restrictive, Qp:Qs ratio approached 1.4:1 as the diameter reaches 2.0 mm ( Figure 3 ). The reduction of the distal pulmonary arterial flow and pressure corresponded with higher cerebral and coronary blood flow (Table 1) . Consequently, while systemic arterial oxygen saturations became lower, systemic and cerebral oxygen delivery improved, with resultant higher mixed venous saturations. This relationship between oxygen delivery and PA banding size achieved maximal oxygen delivery when the branch PAs were restricted to 2 mm, as further luminal reduction to 1.5 mm led to Qp:Qs less than 1 and worse oxygen delivery. However, to achieve this optimal Qp:Qs and maximal oxygen delivery, there is a significant cost to right ventricular performance. The higher afterload associated with restrictive branch PA banding to 2 mm led to a 20% decrease in ejection fraction and a 15% loss in ventricular mechanical efficiency and stroke work when compared with PA banding of 3.5 mm (Table 1) .
By keeping the PA banding diameter at 2 mm, progressively increasing the aortic arch hypoplasia caused a continuous decrease in coronary and cerebral perfusion. A similar observation is noted when isthmus coarctation is stepwise in severity. However, for both scenarios of RAAO, the detrimental effect on cerebral and coronary perfusion was accentuated when the hypoplasia or stenosis became smaller than 3 mm (Figure 4 ).
For example, the loss of cerebral blood flow with a 3-mm aortic arch was just 5% (relative to 5-mm arch), but soared to 24% when the arch was at 2 mm. At the same time, decrease in coronary flow reached 25% in the 2-mm model versus 6% in the 3-mm model. Likewise, with a 2.5-mm isthmus coarctation, the resulting losses of coronary and cerebral blood flow (with respect to the no coarctation model) were 25% and 20%, respectively, compared with 14% and 9%, respectively, in the 3-mm coarctation model.
DISCUSSION
The hybrid stage 1 palliation for HLHS is emerging as an alternative to the surgical Norwood procedures. In addition to avoiding the myocardial dysfunction and instability of systemic and pulmonary vascular resistances associated with neonatal cardiopulmonary bypass and circulatory arrest, the hybrid procedure has other advantages over the surgical Norwood palliation, including providing a pulmonary blood flow that is not dependent on a shunt from the systemic circulation or a right ventricular incision. However, PA banding can accentuate right ventricular afterload and lead to suboptimal myocardial function, and reproducible optimal regulation of pulmonary blood flow through bilateral branch banding remains difficult to achieve. 2, 12 Notwithstanding these differences, the hybrid palliation shared the same objectives as the surgical Norwood procedures: to effective palliate patients with HLHS through the neonatal period with minimal morbidity and mortality, preserving ventricular function, while allowing normal growth and development, especially in the pulmonary vascular bed. Although the question if the hybrid approach should be adopted for all patients with HLHS remains unanswered, we have recently used a sophisticated multiscale modeling approach to highlight some of the hemodynamic and physiologic differences between the hybrid approach and Norwood operations. 4 In this article, we sought to examine the physiologic effect of bilateral branch PA banding on the hybrid palliation and to assess the influence of aortic arch hypoplasia or isthmus coarctation on coronary and cerebral perfusion when blood flow is obligatorily retrograde through the aortic arch.
These simulation results suggest that, within the PA banding sizes modeled, the best oxygen delivery may be achieved when the branch PA luminal diameter is restricted to 2 mm. It was recognized early on in the hybrid experiences that although ductal patency can be fairly reliably maintained with modern stent technology or prostaglandin, restricting pulmonary blood flow through bilateral branch PA banding was particularly challenging in patients with HLHS. 13, 14 Indeed, the majority of the high mortality during the ''learning curve'' period of the hybrid experience was due to pulmonary overcirculation and right ventricular failure. Although several branch PA banding techniques have been described, achieving consistent and optimal pulmonary blood flow restriction remains difficult. This is supported by the wide range of Qp:Qs reported from the Toronto group in patients after the hybrid procedure (0.4-5.7; mean, 1.7 AE 1.0), with a Qp:Qs ratio greater than 2:1 in 28% of the patients and greater than 3:1 in 11% of patients. 12 Although our data do not provide a technical breakthrough in how to perform the optimal surgical branch PA banding, they do highlight that a small variance in luminal constriction can lead to a great discrepancy in systemic oxygen delivery and ventricular performance.
However, our simulations also demonstrated that incrementally increasing the afterload on the right ventricle by tightening the bilateral PA banding leads to progressively lower ejection fraction and worse ventricular mechanical efficiency. The pressure-volume loops generated from the heart component of the multiscale model also predicted progressive loss of stroke work with tighter PA banding. In biventricular animal models, pressure overloading with PA banding can cause right ventricular injury and hypertrophy. Immediately after banding, there is myocardial inflammation and myofibril damage associated with increased expression of cellular adhesion molecules that is associated with myocyte apoptosis. 15, 16 Downregulation of calciumbinding proteins also occurs, and there is decreased mRNA encoding for proteins associated with calcium release, both of which directly have a detrimental effect on myocardial contractility. 17, 18 Taken together, it can be surmised that to achieve the optimal PA banding, balanced Qp:Qs, and maximal systemic oxygen delivery in the hybrid palliation, there is a cost in ventricular performance. Whether this feature of the hybrid palliation has an impact on later ventricular function and outcome after a comprehensive stage 2 or Fontan procedure will require careful examination.
Whereas the surgical Norwood procedures lead to an unobstructed ventricular outflow and antegrade cerebral perfusion, obligatory retrograde aortic arch flow in the hybrid palliation due to aortic atresia or severe aortic stenosis can place coronary and cerebral perfusion in jeopardy if there is pre-ductal restriction. RAAO has been realized as an important complication of the hybrid palliation, with an incidence of 10% to 24%, and, in some centers, pre-intervention recognition of a substrate for obstruction is a contraindication to the hybrid approach. 19 However, there is no quantitative preoperative guideline to assess whether the potential RAAO warrants abandoning the hybrid approach. Our simulation results suggest that, in addition to isthmus coarctation, severe aortic arch hypoplasia can equally result in cerebral and coronary malperfusion. Moreover, the accentuated loss in cerebral and coronary perfusion when isthmus coarctation or aortic arch hypoplasia is less than 3 mm would suggest that the influence of RAAO on cerebral and coronary perfusion is not linear. Whether aortic arch or isthmus diameter more than 3 mm would be safe to proceed with hybrid palliation will require more detailed clinical correlation. However, the simulation results would suggest that caution should be raised on whether to proceed with hybrid palliation when preoperative imaging reveals isthmus narrowing or artic arch hypoplasia less than 3 mm.
It is interesting to observe that the presence of RAAO has little influence on other systemic parameters ( Table 2) . There is little change in Qp:Qs, because Qs decreases only because of the reduction in cerebral flow as lower body flow is maintained. There are no significant differences in the ejection fraction or ventricular efficiency, and the mixed venous and systemic arterial saturation is not altered. However, this observation does highlight how coronary or cerebral malperfusion may occur underdetected in these patients because of flow reduction despite optimal systemic arterial and venous saturations. Last, we did not model a recent modification proposed by the Toronto group to the hybrid palliation, that is, a shunt between the main PA and the brachiocephalic artery was added to provide additional blood flow into the retrograde aortic arch. 20 However, a recent modeling study that applied a similar methodology as ours suggests that this reversed modified Blalock-Taussig shunt can ameliorate the reduced cerebral and coronary perfusion when RAAO exists. 21 Despite the advantages of being able to correlate local pressure and flow effects of hybrid stage 1 palliation with systemic physiologic parameters, the multiscale modeling approach used in this report has some limitations. Present mathematic modeling studies, including ours, remain unable to completely account for biologic adaptation and cardiovascular autoregulation, including the coronary circulation. For example, the effect of cyanosis on myocardial function and vascular tone cannot be simulated. Also, physical growth and the accompanying physiologic maturation are not accounted for. Ventricular adaptation to different volume-loading conditions is not well understood and may variably affect the resulting right ventricular performance acutely and chronically. It should also be noted that we elected to model the ascending aorta and transverse arch with uniform diameters, which may not be the case in all patients with HLHS. Because a wide variation exists in terms of aortic arch dimensions, where differences between ascending aorta and arch are typically small, adopting a uniform dimension in the modeling would have minimal effect on the study focus, which is to highlight the general hemodynamic and physiologic influence of PA banding and RAAO. Last, as complex as they are becoming, mathematic modeling studies such as this remain unable to predict clinical outcome or dictate management decisions. However, they can shed light on some of the relative hemodynamic and physiologic effects of different operative approaches, as demonstrated in this study on the influence on PA banding and RAAO in hybrid stage 1 palliation.
CONCLUSIONS
These computational results suggest that small differences in the degree of branch pulmonary arterial banding can result in significant changes in the overall performance of the hybrid palliation. To obtain a balanced Qp:Qs and thus optimal systemic oxygen delivery, the heightened afterload produced by the pulmonary arterial banding can lead to worse ventricular function. Furthermore, retrograde aortic arch hypoplasia or obstruction can lead to suboptimal cerebral and coronary perfusion. Precise PA banding may be important to optimize interstage physiology in patients undergoing the hybrid approach, and pre-interventional imaging of the aortic arch and isthmus should be performed to rule out potential for post-procedural suboptimal cerebral and coronary perfusion.
APPENDIX: EFFECT OF PULMONARY ARTERY BANDING LENGTH
Proof: ''Doubling the length of the PA bands does not have a significant effect on resistance and therefore exerts negligible effect on pulmonary pressure. It is the degree of restriction on pulmonary arterial diameter that regulates the pressure difference.' ' We may approximately estimate the pressure decrease generated by a pulmonary banding using simple hydraulic formulae describing the flow through a tube of area (A) with a stenosis with a length L b and pulmonary banding producing an area A b , as depicted in Appendix Figure 1 .
The pressure difference (P 1 -P 2 ) can be calculated as the sum of the viscous losses along the stenotic length L b and losses generated by the abrupt contraction and expansion of the tube: ðP 1 ÀP 2 Þ ¼ DP visc þDP cont þDP exp For the sake of simplicity, DP viscous can be evaluated with the Poiseuille relation for laminar flow viscous losses:
where m is the dynamic viscosity and Q is the mean flow rate. Pressure losses in contraction and expansion tracts can be described as flow-quadratic terms, in which losses depend on the A b /A ratio (eg, Brater and King 1 ), namely:
We can note that only the DP visc term depends on L b . By assuming a flow rate of 0.6 L/min across the banding of 2 mm and typical properties for the blood (m ¼ 0.0035 Pa$s, r ¼ 1060 kg/m 3 ), the difference obtained in a pulmonary vessel of 5 mm in diameter for L b ¼ 1.6 mm or L b ¼ 3 mm is minimal. Indeed, DP visc is 1.0 and 2.0 mm Hg, respectively. DP cont and DP exp are always 17 and 28 mm Hg, respectively. Thus, for L b ¼ 1.5 mm, (P 1 -P 2 ) ¼ 46 mm Hg, whereas for L b ¼ 3 mm, (P 1 -P 2 ) ¼ 47 mm Hg.
These calculations indicate that the linear term plays a marginal role with respect to the nonlinear terms in determining the total pressure decrease (1-2 mm Hg vs 45 mm Hg). If the banding does not create an abrupt change, but is more gradual, the DP would slightly decrease, especially for the DP cont term, but the DP visc term that is length dependent would remain nonsignificant.
